Plavix Side Effects Lawsuit News Archive

Aspirin, Plavix Not Good Stroke Prevention Combo
- Medpage Today
02/07/2012 - Combining clopidogrel (Plavix) with aspirin did not prevent recurrent stroke deep in the brain, and even increased the risk of bleeding and death, according to a double-blind, randomized trial that was halted.
READ MORE::

Study Shows Allergies to Plavix Can Be Overcome
- News Wise
01/14/2012 - Allergies to Plavix®, also know by its chemical name, Clopidogrel occur in about six percent of patients given the drug, vital for the prevention of life-threatening stent thrombosis after angioplasty and percutaneous coronary interventions. Researchers at Thomas Jefferson University found that a combination of steroids and antihistamines can successfully alleviate the allergic reaction and enable patients to remain on the drug. Until now, hypersensitivity required drug interruption, placing the patient at risk for restenosis or a major coronary event.
READ MORE::

Medical House Call: DNA swab can see if Plavix works for you
- WDAM News
01/12/2012 - Plavix is prescribed each month to millions of Americans with heart disease. The blood clotting drug is the number two heart pill in the world, behind Lipitor, but it doesn't work for everyone. Dr. Charles Mayes, a Cardiologist at Wesley Medical Center said, "We know that about 30% of the population has some element of resistance to Plavix. They don't get the full anti-coagulation or blood thinning effect."
READ MORE::

Scripps doctors defend Plavix test for coronary stent patients
- North County Times
01/11/2012 - There's no need to perform a certain genetic test before deciding whether to prescribe the anti-clotting drug clopidogrel (Plavix), according to a new study published in the Journal of the American Medical Association. However, doctors at Scripps Health who have pioneered the use of this test say Plavix testing is indeed helpful in preventing heart attacks and deaths in coronary stent patients, and that the JAMA study is flawed.
READ MORE::

Plavix Study Halted by Higher Rate of Bleeding and Death
- Ennis & Ennis
01/04/2012 - A recent study conducted by the National Institute of Neurological Disorders (NINDS) to determine if Plavix-aspirin therapy could prevent recurring strokes in people who had recently suffered subcortical strokes was halted after patients on Plavix-aspirin therapy suffered a higher-than-expected number of bleeding events compared to subjects taking aspirin alone. The Plavix-Aspirin arm involved 3,000 patients.
READ MORE::

New study challenges FDA warning on Plavix
- Examiner Health
12/29/2011 - A new study, which was published December 27 in the Journal of the American Medical Association (JAMA), challenged the Food and Drug Administration’s (FDA) “black box” warning for the drug while also casting doubt on the usefulness of a genetic test for taking clopidogrel (Plavix), which is marketed by Bristol-Myers Squibb Co. and Sanofi SA.
READ MORE::

Anti-clot drug combinations boost bleeding risks
-Reuters
06/03/2009 - CHICAGO - Heart patients are often given two or three different drugs to prevent life-threatening blood clots but these combinations can double, triple or even quadruple the risk of stomach or intestinal bleeding, U.S. researchers said on Tuesday.
READ MORE::

Heartburn drugs affect anti-clotting drugs
-UPI
05/07/2009 - The anti-clotting action of the medication clopidogrel -- Plavix -- can be compromised by common drugs for the treatment of heartburn, U.S. researchers said.
READ MORE::

Plavix [Clopidogrel bisulfate] FDA safety review to evaluate differences in efffectiveness, genetic factors, potential drug interactions
-FDA MedWatch
01/26/2009- FDA notified healthcare professionals that the makers of Plavix have agreed to work with FDA to conduct studies to obtain additional information that will allow a better understanding and characterization of the effects of genetic factors and other drugs (especially the proton pump inhibitors (PPIs)) on the effectiveness of clopidogrel.
READ MORE::

Trouble in Trialville: Plans for Post-DES Clopidogrel Trial Get Bogged Down Over Trial Design, Leadership.
04/13/2008- Almost 16 months after an FDA hearing into drug-eluting stent (DES) safety emphasized the need for a randomized clinical trial to determine, once and for all, the optimal duration of clopidogrel (Plavix, Sanofi-Aventis) plus aspirin after DES implantation, researchers, government agencies, and industry sponsors cannot agree on how it should move ahead.
READ MORE::

Increased Rate of Heart Attack, Death Linked to Halting Plavix
-Wall Street Journal
02/06/2008 - Patients treated for heart attack or angina and given the anticlotting drug Plavix had a sharply increased rate of death or heart attack within 90 days after being taken off the drug, researchers found.
READ MORE::

Whistleblowers Responsible for Half-Billion Dollar Fraud Recovery Against Bristol Myers
-National Whistleblower Center 10/1/2007- Several whistleblowers provided confidential information to the United States Department of Justice which resulted in a $515 million taxpayer recovery against the drug company Bristol Myers to settle health care fraud allegations.
READ MORE::

Under no circumstances should you discontinue taking any medication, including Plavix, without first consulting with your doctor.

If you or a loved one have experienced Plavix Side Effects you may be entitled to compensation. Contact the Plavix attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and lawyers are standing by to answer any questions you may have regarding Plavix side effects, a possible Plavix class action lawsuit, or any other type of Plavix litigation. Call us toll-free at: 1.800.856.6405 or fill out the free case evaluation form on this page.

Plavix Side Effects Lawsuit